My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects.
Glass, O, Dreusicke, M, Evans, J, Bechard, E, and Wolever, RQ. "Expressive writing to improve resilience to trauma: A clinical feasibility trial." Complementary Therapies in Clinical Practice 34 (February 2019): 240-246.
Glass, OK, Bowie, M, Fuller, J, Darr, D, sary, JU, Boss, K, Choudhury, KR, Liu, X, Zhang, Z, Locasale, JW, Williams, C, Dewhirst, MW, Jones, LW, and Seewaldt, V. "Differential response to exercise in claudin-low breast cancer(Published online)." Oncotarget (September 19, 2017).
Glass, OK, Ramalingam, S, and Harrison, MR. "Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss." Clin Adv Hematol Oncol 14, no. 6 (June 2016): 436-446. (Review)
Glass, OK, Inman, BA, Broadwater, G, Courneya, KS, Mackey, JR, Goruk, S, Nelson, ER, Jasper, J, Field, CJ, Bain, JR, Muehlbauer, M, Stevens, RD, Hirschey, MD, and Jones, LW. "Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study." Br J Cancer 112, no. 5 (March 3, 2015): 825-831.
Glass, O, Inman, BA, Courneya, KS, Mackey, JR, Nelson, E, Hartman, Z, and Jones, LW. "Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands.": American Association for Cancer Research (AACR), April 15, 2013.
Hartman, ZC, Wei, J, Glass, OK, Guo, H, Lei, G, Yang, X-Y, Osada, T, Hobeika, A, Delcayre, A, Le Pecq, J-B, Morse, MA, Clay, TM, and Lyerly, HK. "Increasing vaccine potency through exosome antigen targeting." Vaccine 29, no. 50 (November 2011): 9361-9367.
Hartman, ZC, Yang, X-Y, Glass, O, Lei, G, Osada, T, Dave, SS, Morse, MA, Clay, TM, and Lyerly, HK. "HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis." Cancer Research 71, no. 13 (July 2011): 4380-4391.
Hartman, ZC, Osada, T, Glass, O, Yang, XY, Lei, G-J, Lyerly, HK, and Clay, TM. "Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity." Cancer Research 70, no. 18 (September 7, 2010): 7209-7220.
Hartman, ZC, Wei, J, Osada, T, Glass, O, Lei, G, Yang, X-Y, Peplinski, S, Kim, D-W, Xia, W, Spector, N, Marks, J, Barry, W, Hobeika, A, Devi, G, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 16, no. 5 (March 2010): 1466-1477.
Osada, T, Yang, XY, Hartman, ZC, Glass, O, Hodges, BL, Niedzwiecki, D, Morse, MA, Lyerly, HK, Amalfitano, A, and Clay, TM. "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity." Cancer Gene Ther 16, no. 9 (September 2009): 673-682.